Given that SLC38A5 as well as SLC38A2 might have relevance to breast cancer growth and progression, we analyzed the expression of these two transporters in breast cancer using the TCGA (The Cancer Genome Atlas) database. Here, SLC38A2 is linked to breast carcinoma.